Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lucier, William Rastetter, David Broad, Les Cross, Magda Marquet, Scott Salka, James Schaeffer, Bob Sullivan, David Marino, Tony Hickson, Barbara Alving, Elias Zerhouni

Premium
Biocom, the association for the Southern California life science community, last week announced eight new members of its 2007-2008 board of directors.
 
The chairman of Biocom’s board for 2007-2008 is Greg Lucier, president and CEO of Carlsbad-based Invitrogen.
 
Other members include: 
  • William Rastetter, venture partner, Venrock Associates
  • David Broad, vice president and general manager, Oceanside product operations, Genentech
  • Les Cross, CEO and president, DJ Orthopedics
  • Magda Marquet, co-president and co-CEO, Althea Technologies
  • Scott Salka, CEO, Ambit Biosciences
  • James Schaeffer, executive director, worldwide licensing and external research, West coast, Merck Research Laboratories
  • Bob Sullivan, dean, Rady School of Management, University of California, San Diego
  • David Marino, principal and executive vice president, Irving Hughes Group

 
The Council for Entrepreneurial Development of Research Triangle Park, NC, last week announced that Tony Hickson, head of bioscience licensing at Imperial College Innovations in London, will deliver a keynote address at CED’s 16th Annual Biotech Conference, May 14-15 in Durham, NC.
 
Other keynote speakers at the event will include former Senate majority leader Tom Daschle; and stem-cell researcher Anthony Atala, professor, chair, and director at the Institute for Regenerative Medicine, Wake Forest University Baptist Medical Center.
 

 
Barbara Alving has been named director of the National Center for Research Resources, part of the National Institutes of Health, the NIH said last week.
 
Alving has been serving as the NCRR’s acting director since 2005, but NIH Director Elias Zerhouni recently officially appointed her to the position.
 
Alving has worked as a public health officer for the US Food and Drug Administration on the NIH campus; as chief of the department of hematology and vascular biology at Walter Reed Army Institute of Research; chief of the department of hematology and oncology at the Washington Hospital Center; and a director of the division of blood diseases and resources at the National Heart, Lung, and Blood Institute.
 
She also is a professor of medicine at the Uniformed Services University of Health Sciences, and has been a member of various committees on hematology.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.